SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gliatech (GLIA)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (1168)1/20/2000 12:39:00 AM
From: scaram(o)uche  Read Replies (1) of 2001
 
2000 objectives..... Approval for -L in Japan (Chugai). Begin U.S. manufacturing for Adcon-L. Regulatory submission for -T/N. File PMA for Adcon-P, and sign distribution agreement. Begin phase II for Perceptin and partner it with a pharma. Begin pivotal trial, Adcon-A. Complete humanization of anti-properdin.

Of these, which might happen at any time?

Partner Perceptin with a pharma?
Begin phase II for Perceptin?
Approval for Adcon-L in Japan?
Regulatory submission for Adcon-T/N?
Sign distribution agreement for Adcon-P?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News